Effective disease control in a laboratory animal facility relies on systematic identification of potential disease risks—including infectious agents, vecto
Topic Synopsis
Effective disease control in a laboratory animal facility relies on systematic identification of potential disease risks—including infectious agents, vectors, fomites, and zoonotic threats—followed by rigorous application of biosecurity measures, sanitation protocols, and health monitoring programmes. This element equips learners to critically evaluate and implement strategies such as quarantine, barrier housing, personnel hygiene, environmental decontamination, and waste management to minimise pathogen introduction and spread, thereby safeguarding animal welfare and research integrity.
Key Concepts & Core Principles
- The 3Rs (Replacement, Reduction, Refinement): Core ethical framework for minimising animal use and suffering in research. Replacement involves using non-animal methods where possible; Reduction means using the minimum number of animals to achieve statistical significance; Refinement improves welfare through better housing, handling, and procedures.
- Animals (Scientific Procedures) Act 1986 (ASPA): The primary UK legislation regulating the use of protected animals in scientific procedures. It requires three licences: establishment, project, and personal. Understanding the licensing hierarchy and conditions is essential for compliance.
- Species-specific husbandry: Each species (e.g., mice, rats, zebrafish) has unique behavioural, nutritional, and environmental needs. For example, mice require social housing and environmental enrichment to prevent stereotypic behaviours, while zebrafish need controlled water quality and photoperiods.
- Health monitoring and disease prevention: Regular health checks, sentinel programmes, and biosecurity measures are vital to maintain specific pathogen-free (SPF) status. Common diseases like murine norovirus or ringtail can compromise research validity and animal welfare.
- Ethical review and project licensing: All scientific procedures must undergo ethical review by an Animal Welfare and Ethical Review Body (AWERB). Project licences detail the severity classification, endpoints, and justification for animal use, balancing potential benefits against harms.
Exam Tips & Revision Strategies
- Always frame your answers in the context of the specific facility type—barrier, conventional, or containment—and the species housed, as protocols vary significantly.
- When evaluating control methods, use the hierarchy of controls (elimination, substitution, engineering controls, administrative controls, PPE) and relate each to a specific risk you have identified.
- Structure your responses clearly: first state the risk, then propose at least two alternative control strategies with advantages and limitations, and finally recommend the most appropriate with justification.
Common Misconceptions & Mistakes to Avoid
- Confusing disinfection and sterilisation, or applying chemical agents incorrectly (e.g., using a bactericide against spores, or failing to account for contact time and organic load).
- Overlooking fomite transmission from equipment, clothing, or environmental surfaces, focusing solely on direct animal-to-animal contact.
- Ignoring the role of human behaviour in biosecurity breaches, such as neglecting hand hygiene or failing to follow gowning sequences.
Examiner Marking Points
- Award credit for demonstrating accurate identification of specific disease agents relevant to the facility’s species, including bacterial, viral, fungal, and parasitic pathogens, with clear differentiation between obligatory and opportunistic pathogens.
- Award credit for systematically evaluating risk factors such as animal source, transport, feed, bedding, water, air quality, personnel, visitors, and pests, and for linking each risk to a control method (e.g., HEPA filtration, autoclaving, footbaths, restricted access).
- Award credit for providing a coherent, evidence-based comparison of preventive strategies, including vaccination, sentinel monitoring, routine health screening, and the use of specific pathogen-free (SPF) stock, justifying choices with reference to the 3Rs and facility capabilities.